Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCLASS: Clarithromycin for Sepsis
NCT03345992Phase 3Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of clarithromycin in sepsis, sponsored by Hellenic Institute for the Study of Sepsis. Started Dec 2017; status: completed.
02
Drugs
clarithromycin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03345992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345992.